Clinical Trial

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 22, 2024 (before its estimated May 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-09-09; most recent amendment 2024-02-21.
Status change: Not Yet Recruiting → Recruiting 2022-06-16
Trial Details
NCT Number NCT05049057
Lead Sponsor Henry M. Jackson Foundation for the Advancement of Military Medicine
Conditions Posttraumatic Headache, Mild Traumatic Brain Injury
Enrollment 404 participants
Start Date 2022-07-19
Primary Completion 2026-05-19 (estimated)
Study Completion 2027-05-19 (estimated)
Updated on ClinicalTrials.gov 2024-02-22